• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗心绞痛制剂对缺血性心脏病患者的治疗效果与其对血液流变学特性的影响之间的关系]

[Relation between therapeutic efficacy of antianginal preparations in patients with ischemic heart disease and their effect on the rheologic properties of blood].

作者信息

Furkalo N K, Ivashchenko T I, Romanenko A I

出版信息

Kardiologiia. 1985 Sep;25(9):55-9.

PMID:3935849
Abstract

The effects of a variety of currently-used anti-anginal drugs on major hemorheologic parameters (blood viscosity in the 0.692-2348 s-1 variation rates range, plasma viscosity, erythrocyte and platelet function) and also the hemostatic system were examined in 100 chronic coronary patients during specific treatment courses. The nitrates, beta-blockers (alone or in combinations), cordaron and molsidomin were shown to produce positive effects on blood rheology. A relationship was demonstrated between physical stress tolerance and blood viscosity pattern in propranolol-treated coronary patients. It is suggested that positive hemorheologic effects of anti-anginal drugs may be an important constituent of their therapeutic action and, as such, provide an additional marker of their efficiency in coronary heart disease.

摘要

在100例慢性冠心病患者接受特定疗程治疗期间,研究了多种目前使用的抗心绞痛药物对主要血液流变学参数(0.692 - 2348 s-1变化率范围内的血液粘度、血浆粘度、红细胞和血小板功能)以及止血系统的影响。结果显示,硝酸盐类、β受体阻滞剂(单独使用或联合使用)、胺碘酮和吗多明对血液流变学产生了积极影响。在接受普萘洛尔治疗的冠心病患者中,身体应激耐受性与血液粘度模式之间存在关联。提示抗心绞痛药物的积极血液流变学效应可能是其治疗作用的重要组成部分,因此可作为其在冠心病治疗中疗效的额外指标。

相似文献

1
[Relation between therapeutic efficacy of antianginal preparations in patients with ischemic heart disease and their effect on the rheologic properties of blood].[抗心绞痛制剂对缺血性心脏病患者的治疗效果与其对血液流变学特性的影响之间的关系]
Kardiologiia. 1985 Sep;25(9):55-9.
2
[Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].[吗多明和硝酸异山梨酯在外周循环中的疗效及作用持续时间]
Fortschr Med. 1985 Oct 10;103(38):903-6.
3
[Molsidomin compared to nitrates. Use in patients with manifest coronary disease].
MMW Munch Med Wochenschr. 1979 Sep 7;121(36):1149-51.
4
[Various aspects of drug therapy of chronic forms of ischemic heart disease].[慢性缺血性心脏病的药物治疗的各个方面]
Kardiologiia. 1985 Sep;25(9):37-40.
5
[Comparative examinations of the effectiveness of Molsidomin and nitrates in angina pectoris].
Med Welt. 1980 Jul 25;31(29-30):1099-103.
6
Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.吗多明、硝酸甘油和硝酸异山梨酯对犬实验性诱导冠状动脉血栓形成的影响比较。
Basic Res Cardiol. 1984 Sep-Oct;79(5):503-12. doi: 10.1007/BF01910479.
7
[Rheological properties of blood in patients with stenocardia during treatment with obsidan, corvatone and corinfar].[心绞痛患者在使用奥昔丹、可伐托宁和可立弗治疗期间血液的流变学特性]
Vrach Delo. 1985 Apr(4):19-21.
8
[Clinical evaluation of molsidomin in ischemic cardiopathy].[硝普钠在缺血性心脏病中的临床评估]
Clin Ter. 1984 Oct 31;111(2):141-6.
9
The activity of molsidomine in experimental models of ischemic cardiac disease.
Am Heart J. 1985 Mar;109(3 Pt 2):631-6. doi: 10.1016/0002-8703(85)90668-4.
10
Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
Int J Clin Pharmacol Ther Toxicol. 1984 May;22(5):246-9.